Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Magseed Pro Magnetic Marker System

K-Number: K232865 · 2024-06-28

ApplicantEndomagnetics Ltd.,
Decision Date2024-06-28
Product CodeNEU
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Magseed Pro Magnetic Marker System is a medical device manufactured by Endomagnetics Ltd.,. It received FDA 510(k) clearance on 2024-06-28 under approval number K232865. The device is classified under product code NEU. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Magseed Pro Magnetic Marker System?

Magseed Pro Magnetic Marker System is a medical device that received FDA 510(k) clearance on 2024-06-28. It is manufactured by Endomagnetics Ltd.,. The 510(k) number is K232865.

When was Magseed Pro Magnetic Marker System approved by the FDA?

Magseed Pro Magnetic Marker System received FDA 510(k) clearance on 2024-06-28, under approval number K232865.

What company makes Magseed Pro Magnetic Marker System?

Magseed Pro Magnetic Marker System is manufactured by Endomagnetics Ltd.,.

What is the FDA product code for Magseed Pro Magnetic Marker System?

The FDA product code for Magseed Pro Magnetic Marker System is NEU.

Related Clinical Trials

NCT01143454 Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System RECRUITING NCT03331380 Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System RECRUITING NCT07609511 Magnet System Gastric Outlet Obstruction Study NOT_YET_RECRUITING NCT07608614 Sleep and Performance RECRUITING NCT07544654 DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy NOT_YET_RECRUITING NCT00453505 Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System COMPLETED

Other Devices by Endomagnetics Ltd.,

K153044Sentimag System, Sentimark Magnetic Marker Systerm K163541Magseed Magnetic Marker System K173587Magseed Magnetic Marker Systtem K222832Sentimag System PMA P160053Lymph node location system during sentinel biopsy procedure

Related Devices (Code: NEU)

K152510UltraCor Twirl Breast Tissue MarkerBard Peripheral Vascular, Inc. K161021HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. K171767Cianna Medical SAVI Scout Reflector and SAVI Scout SystemCianna Medical, Inc. K170803HydroMARK Breast Biopsy Site MarkersDevicor Medical Products, Inc. K170026Radiopaque Tissue MarkerViscus Biologics, LLC K170905Star Tissue MarkerScion Medical Technologies, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑